期刊文献+

乳酸杆菌脂磷壁酸抑制脂多糖诱导的大鼠肝脏Kupffer细胞TLR4通路的激活 被引量:2

Lipoteichoic Acid of Lactobacillus Bulgaricus Inhibits the Lipopolysaccharide-activated TLR4 Pathway in Rat Kupffer Cells
原文传递
导出
摘要 目的:探讨保加利亚乳酸杆菌脂磷壁酸(Lipoteichoic Acid of lactobacillus bulgaricus, LBG-LTA)对大鼠肝脏Kupffer细胞Toll样受体4(Toll-like receptor4,TLR4)信号通路的作用。方法:雄性健康Wistar大鼠10只(2月龄,体重250~300g)处死后。分离培养肝脏Kupffer细胞;培养LBG,并提取制备LBG-LTA;Kupffer细胞,在有或无LBG-L11A(0.1、1、10wg/mL)预处理的情况下,给予脂多糖(lipopolysaccharide,LPS,1EU/mL)刺激后,Westernblot检测各孔Kupffer细胞的TLR4、TANK结合激酶1(TANK binding kinase-1,TBK1)及核中的核因子B(nuclear factor-κB,NF-κB)水平,酶联免疫吸附法检测各孔培养上清中的肿瘤坏死因子α(tumornecrosisfactor-α,TNF-α)和白介素1β(interleukin-1β,IL-1β)。结果:分离的Kupffer细胞经不同浓度LBG-LTA预处理后,其在LPS刺激下所表达的TLR4、TBK1、核中NF-B的水平及生成的TNF-a和IL-1β明显低于无LBG-LTA预处理情况下的LPS孔(P〈0.05),且LBG-LTA的作用呈浓度依赖性。结论:LBG-LTA以浓度依赖的方式抑制了LPS诱导下大鼠Kupffer细胞TUM通路的激活。 Objecfive: To determine whether Lipoteichoic Acid of lactobacillus bulgaricus (LBG-LTA) inhibits ToU-like receptor 4 (TLR4) pathway in Kupffer cells isolated from rats. Methods: Ten healthy male Wistar rats, 2 months old, 250-300 g, were killed for the isolation of Kupffer ceils. Isolated Kupffer cells were treated with lipopolysaccharide (LPS, 1 EU/mL) with or without LBG-LTA (0.1, 1 or 10μg/mL) pretreatment. The expression of TLR4, TANK binding kinase-1 (TBK 1) and activated nuclear factor-κB (NF- B) in Kupffer cells was measured by Western blot. The production of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) was quanti- fied by ELISA. Results: The LPS-induced expression of TLR4, TBK1 and activated NF- B and production of TNF-α and IL-1β in isolat- ed Kupffer cells were significantly inhibited by LBG-LTA pretreatment in a dose-dependent manner (P〈0.05). Conclusions: LBG-LTA inhibits LPS-activated TLR4 pathway in Kupffer ceils of rats in a dose-dependent manner.
出处 《现代生物医学进展》 CAS 2015年第21期4009-4013,共5页 Progress in Modern Biomedicine
基金 四川省卫生厅资助项目(100496)
关键词 KUPFFER细胞 TOLL样受体4 乳酸杆菌 脂磷壁酸 Kupffer cells Toll-like receptor 4 Lactobacilli Lipoteichoic Acid
  • 相关文献

参考文献28

  • 1Bhala N, Jouness RI, Bugianesi E. Epidemiology and natural history ofpatients withNAFLD[J]. CurrPharm Des, 2013, 19(29): 5169-5176.
  • 2Bhala N, Angulo P, van der Poorten D, et al. The natural history ofnonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: aninternational collaborative study [J]. Hepatology, 2011, 54 (4):1208-1216.
  • 3Csak T, Velayudham A, Hritz I,et al. Deficiency in myeloiddifferentiation factor-2 and toll-like receptor 4 expression attenuatesnonalcoholic steatohepatitis and fibrosis in mice [J]. Am J PhysiolGastrointest Liver Physiol, 2011, 300(3): G433-441.
  • 4Tosello-Trampont AC, Landes SG, Nguyen V,et al. Kuppfer cellstrigger nonalcoholic steatohepatitis development in diet-inducedmouse model through tumor necrosis factor-a production [J]. J BiolChem,2012, 287(48): 40161-40172.
  • 5Ye D, Li FY, Lam KS, et al. Toll-like receptor-4 mediatesobesity-induced non-alcoholic steatohepatitis through activation ofX-box binding protein-1 in mice[J]. Gut, 2012,61(7): 1058-1067.
  • 6Wenfeng Z, Yakun W,Di M, et al. Kupffer cells: increasinglysignificant role in nonalcoholic fatty liver disease [J]. Ann Hepatol,2014,13(5): 489-495.
  • 7Tang T, Sui Y,Lian M, et al. Pro-inflammatory activated Kupffer cellsby lipids induce hepatic NKT cells deficiency throughactivation-induced cell death[J]. PLoS One,2013, 8(12): e81949.
  • 8Gohda J, Matsumura T,Inoue J. Cutting edge: TNFR-associated factor(TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1receptor domain-containing adaptor-inducing IFN-p (TRIF)-dependent pathway in TLR signaling [J]. J Immunol, 2004,173(5):2913-2917.
  • 9Sato S, Sugiyama M, Yamamoto M, et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-p (TRIF) associates with TNFreceptor-associated factor 6 and TANK-binding kinase 1,andactivates two distinct transcription factors, NF-kB and IFN-regulatoryfactor-3, in the Toll-like receptor signaling [J]. J Immunol, 2003, 171(8): 4304-4310.
  • 10Wagnerberger S, Spruss A, Kanuri G, et al. Lactobacillus caseiShirota protects from fructose-induced liver steatosis: a mouse model[J]. JNutr Biochem,2013,24(3): 531-538.

同被引文献34

  • 1王晓军,张荣珍,胡苑笙,梁晓峰.我国病毒性肝炎流行现状研究[J].疾病监测,2004,19(8):290-292. 被引量:150
  • 2毛德文,邱华,黄古叶,胡振斌,刘洁.解毒化瘀Ⅱ方防治急性肝衰竭肝性脑病的实验机制研究[J].天津中医药,2006,23(6):486-489. 被引量:4
  • 3Csak T, Velayudbam A, Hfitz I, et al. Deficiency in myeloid differenti- ation factor-2 and toll-like receptor 4 expression attenuates nonalco- holic steatohepatitis and fibrosis in mice[J]. Am J Physiol Gastrointest Liver Physiol, 2011,300(3): G433-441.
  • 4Ye D, Li FY, Lain KS, et al. Toll-like receptor-4 mediates obesity-in- duced non-alcoholic steatohepatitis through activation of X-box bind- ing protein-1 in mice[J]. Gut, 2012, 61(7): 1058-1067.
  • 5Tosello-Trampont AC, Landes SG, Ngnyen V, et al. Kuppfer cells trig- ger nonalcoholic steatohepatitis development in diet-in duced mouse model through tumor necsis factor-a production [J]. J Biol Chem, 2012, 287(48): 40161-40172.
  • 6Wenfeng Z, Yakun W, Di M, et al. Kupffer cells: increasingly signifi- cant role in nonalcoholic fatty liver disease[J]. Ann Hepatol, 2014, 13 (5): 489-495.
  • 7Gohda J, Matsumura T, Inoue J. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL- 1 receptor domain-containing adaptor-inducing IFN-β (TRIF)-depen- dent pathway in TLR signaling [J]. J Immunol, 2004, 173 (5): 2913-2917.
  • 8Sato S, Sugiyama M, Yamamoto M, et al. TolI/IL-1 receptor domain- containing adaptor inducing IFN-13 (TRIF) associates with TNF re- ceptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-KB and IFN-regulatory factor-3, in the Toll-like receptor signaling [J]. J Immunol, 2003, 171 (8): 4304-4310.
  • 9Wagnerberger S, Spruss A, Kanuri G, et al. Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model [J]. J Nutr Biochem, 2013, 24(3): 531-538.
  • 10Eslamparast T, Poustchi H, Zamani F, et al. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, place- bo-controlled pilot study[J]. Am J Clin Nutr, 2014, 99(3): 535-542.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部